Andrew Kaplan

Andrew Kaplan is a member of the Board of Directors of Beeline Medicines and a Partner at Bain Capital, where he focuses on investments in the healthcare sector as part of the North America Private Equity team. He also serves on the Board of Directors for Kailera Therapeutics, QuVa Pharma, Surgery Partners, U.S. Renal Care, and PCI Pharma Services, and as a Governing Trustee of the Dana-Farber Cancer Institute. Earlier in his career, Mr. Kaplan was an investment banker at Goldman Sachs and co-founded EngagedHealth, a post-hospitalization service focused on improving outcomes and reducing readmissions for chronically ill patients. Mr. Kaplan received an MBA from Harvard Business School, where he was a Baker Scholar, and a B.S. in economics, magna cum laude, from the Wharton School of the University of Pennsylvania.